Original Investigation
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials
Eric L. Simpson, MD; Lawrence F. Eichenfield, MD; Javier Alonso-Llamazares, MD, PhD; et al.
Brief Report
Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants
James J. Abbott, MD; Angela J. Jiang, MD; Rama Godse, MD; et al.
Research Letter
Precocious Puberty Among Children and Adolescents With Hidradenitis Suppurativa
Nicole Mastacouris, MS; Bria Midgette, BS; Andrew Strunk, MA; et al.
Observation
Treatment of Pembrolizumab-Induced Mucocutaneous Lichen Planus With Metronidazole
Sierra Parkinson, BA; Sabah Osmani, MD; Paul B. Googe, MD; et al.
Comment & Response
Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa
Michelle K. Y. Chen, BSc (Med) Hons, MD; Artiene Tatian, MBBS, BAdvSc (Chem); Deshan Frank Sebaratnam, MBBS(Hons), MMed
Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa—Reply
Adam J. N. Raymakers, PhD; Aaron S. Kesselheim, MD, JD, MPH; William B. Feldman, MD, DPhil, MPH
|